Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients? (2013)
- Authors:
- USP affiliated authors: FERREIRA, MARCUS CASTRO - FM ; SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidades: FM; FCF
- Subjects: AGENTES ANTIMICROBIANOS; FARMACOCINÉTICA; QUEIMADURAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Innovations in Pharmaceuticals and Pharmacotherapy
- ISSN: 2321-323X
- Volume/Número/Paginação/Ano: v. 1, n. 2, p. 133-144, 2013
-
ABNT
SANCHES-GIRAUD, Cristina et al. Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients?. Innovations in Pharmaceuticals and Pharmacotherapy, v. 1, n. 2, p. 133-144, 2013Tradução . . Disponível em: http://www.innpharmacotherapy.com/VolumeArticles/FullTextPDF/32_11IPPSAJuly2013.pdf. Acesso em: 28 jan. 2026. -
APA
Sanches-Giraud, C., Gomez, D. de S., Ferreira, M. C., Silva Junior, C. V. da, & Santos, S. R. C. J. (2013). Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients? Innovations in Pharmaceuticals and Pharmacotherapy, 1( 2), 133-144. Recuperado de http://www.innpharmacotherapy.com/VolumeArticles/FullTextPDF/32_11IPPSAJuly2013.pdf -
NLM
Sanches-Giraud C, Gomez D de S, Ferreira MC, Silva Junior CV da, Santos SRCJ. Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients? [Internet]. Innovations in Pharmaceuticals and Pharmacotherapy. 2013 ; 1( 2): 133-144.[citado 2026 jan. 28 ] Available from: http://www.innpharmacotherapy.com/VolumeArticles/FullTextPDF/32_11IPPSAJuly2013.pdf -
Vancouver
Sanches-Giraud C, Gomez D de S, Ferreira MC, Silva Junior CV da, Santos SRCJ. Ciprofloxacin, oxacillin, piperacillin and sulfamethoxazole by systemic administration for the control of severe infections: is dose adjustment required for critical burn patients? [Internet]. Innovations in Pharmaceuticals and Pharmacotherapy. 2013 ; 1( 2): 133-144.[citado 2026 jan. 28 ] Available from: http://www.innpharmacotherapy.com/VolumeArticles/FullTextPDF/32_11IPPSAJuly2013.pdf - Vancomycin dose adjustment in severe burn patients based on trough level for drug effectiveness against pathogens at 1 mg/l minimum inhibitory concentration
- Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets
- Imipenem serum measurements in real time for target attainment against more agressive strains MlC>2mg/l in septic burns
- Vancomycin prescription changes in real time based on drug plasma monitoring against Staphylococcus spp MlC 2mg/l in critically ill paediatric burns
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- Vancomycin effectiveness by PK/PD correlation in burn patients
- PK/PD correlation for imipenem effectiveness in burn patients
- PK/PD correlation of vancomycin for dose adjustment for the control of infections in pediatric critical burn patients
- Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic
- Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics?
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
